Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic biochemical reasoning with no new empirical human data.
PubMed 28852372 · doi:10.1186/s12970-017-0184-9
What was done
The authors conducted a narrative literature review and theoretical biochemical analysis evaluating whether branched-chain amino acids (BCAAs: leucine, valine, and isoleucine) alone stimulate muscle protein synthesis and produce an anabolic response in humans in the post-absorptive state.
What was found
The review identified zero studies in human subjects measuring muscle protein synthesis in response to orally ingested BCAAs alone, and only two studies evaluating intravenous BCAA infusion alone. Both intravenous infusion studies reported that BCAAs decreased muscle protein synthesis as well as muscle protein breakdown (decreasing overall muscle protein turnover), and net catabolism persisted. Theoretically, any maximal increase in muscle protein synthesis in response to BCAAs alone is capped at the baseline difference between breakdown and synthesis (approximately 30%), which is an overestimate due to obligatory oxidation of other essential amino acids.
Why it matters
This paper challenges the widespread commercial premise of isolated BCAA supplementation, showing that BCAAs alone cannot sustain an anabolic response without the full complement of essential amino acids.
Limits
This is a narrative review rather than a formal systematic review or meta-analysis. Direct human data were restricted to two intravenous infusion studies rather than oral supplementation trials, and numerical values for sample sizes, infusion doses, and effect sizes were not provided in the abstract.
Cited by
- supports Branched-chain amino acid (BCAA) supplements provide minimal additional benefit for muscle protein synthesis beyond the specific action of leucine.